A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases
Principal Investigator
Steven Chmura, MD PhD
Status
Terminated
Date Opened To Accrual
August 04 2014
Date Closed to Accrual
March 20 2018
Date of Study Termination
May 20 2022
Disease Site
Breast [BR]
Breast
Phase
I
Developmental Therapeutics
No
Primary Objective
To determine the recommended SBRT dose for each of the metastatic locations being treated given the individual and overlapping fields when multiple metastases are treated with SBRT in a national clinical trials network setting.
Patient Population
Oligometastases arising from the breast, lung or prostate; oligometastases defined as ≤ 4 distinct metastases visualized on standard imaging studies; all metastases not resected must be amenable to SBRT; local and regional disease treated per standard of care with no evidence of progression.
Target Accrual
84
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.